Column Capital Advisors’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$9.4K Hold
285
– – ﹤0.01% 528
2023
Q2
$7.01K Hold
285
– – ﹤0.01% 580
2023
Q1
$10.6K Hold
285
– – ﹤0.01% 544
2022
Q4
$13.1K Hold
285
– – ﹤0.01% 478
2022
Q3
$7K Hold
285
– – ﹤0.01% 506
2022
Q2
$9K Hold
285
– – ﹤0.01% 488
2022
Q1
$10K Buy
285
+142
+99% +$9.28K ﹤0.01% 497
2021
Q4
$15K Hold
143
– – ﹤0.01% 451
2021
Q3
$23K Buy
+143
New +$27.1K ﹤0.01% 365

Other funds holding BDSX

Column Capital Advisors's BDSX Position: Q3 2023 in Review

Column Capital Advisors held its Biodesix (BDSX) position steady in Q3 2023 at 285 shares worth $9.4K. The position accounts for ﹤0.01% of the portfolio, ranked #528.

Column Capital Advisors first reported a position in BDSX in Q3 2021 and has held it in 9 quarters since. The position peaked at $23K in Q3 2021. 37 funds tracked by Wall St. Rank hold BDSX as of Q3 2023.

  • Column Capital Advisors held 285 shares of Biodesix worth $9.4K as of Q3 2023.
  • Column Capital Advisors left its Biodesix share count unchanged in Q3 2023.
  • Biodesix made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #528 holding.
  • Column Capital Advisors first reported a position in Biodesix in Q3 2021 and has held it in 9 quarters since.
  • Column Capital Advisors's Biodesix position peaked at $23K in Q3 2021.
  • 37 funds tracked by Wall St. Rank held Biodesix as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.